Yardley, Denise A. http://orcid.org/0000-0002-8664-3458
Arrowsmith, Edward R.
Daniel, Brooke R.
Eakle, Janice
Brufsky, Adam
Drosick, David R.
Kudrik, Fred
Bosserman, Linda D.
Keaton, Mark R.
Goble, Sharon A.
Bubis, Jeffrey A.
Priego, Victor M.
Pendergrass, Kelly
Manalo, Yvonne
Bury, Martin
Gravenor, Donald S.
Rodriguez, Gladys I.
Inhorn, Roger C.
Young, Robyn R.
Harwin, William N.
Silver, Caryn
Hainsworth, John D.
Burris, Howard A. III
Funding for this research was provided by:
Supported in part by a grant from Bristol-Myer Squibb
Article History
Received: 2 May 2017
Accepted: 5 May 2017
First Online: 15 May 2017
Compliance with ethical standards
:
: Denise A. Yardley is on the speaker bureau for Genentech, Eisai. Mark R. Keaton is a consultant for Biotheranostics, speaker bureau for Biotheranostics, and received travel, accommodations, expenses from Biotheranostics. Sharon A. Gobble received research funding from Bristol-Myers Squibb. Kelly Perdergrass received honoraria from Amgen, and speaker bureau of Amgen and also a consultant for AbbVie, received research funding from Amgen, and travel, accommodations, expenses from AbbVie, Amgen. Gladys I. Rodriguez received honoraria from Genentech and a speaker bureau for Genentech. All the other authors declared that they have no conflict of interest to disclose.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. This article does not contain any studies with animals performed by any of the authors.
: Informed consent was obtained from all individual participants included in the study. This study was conducting within the laws of the United States.